FDA Approves New HIV Drug

The US Food and Drug Administration approved a new HIV drug, Edurant. This medication fights HIV in combination with other antiretrovirals.

Made by the New Jersey based Tibotec Therapeutics, Edurant helps block the virus from replicating and is part of a class of drugs known as non-nucleoside reverse transcriptase inhibitor.

AIDS/HIV Treatment - Drugs - Proteas Inhibitors - NRTIs - NNRTIs
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV

The pill is to be taken once daily with food, the FDA said.

"Patients may respond differently to various HIV drugs or experience varied side effects," said Edward Cox, director of the office of antimicrobial products in the FDA's Center for Drug Evaluation and Research.

"FDA's approval of Edurant provides an additional treatment option for patients who are starting HIV therapy."

Quiz on HIV / AIDS
Statistics tell us that the world HIV+ population has risen drastically from 8 million in 1990 to a whopping 33 million in 2007! Even more alarming is the fact that young people (below the age of 25) account for half of these infections! This is adequate proof for the lack of awareness among the general public even in these modern times. So take our quiz and brush up on the essential facts of HIV/AIDS.

There are 10 questions on HIV / AIDS in this quiz that will explore the depth of your knowledge and provide answers to the following:

Immune control of HIV ()
Symptoms of HIV/AIDS ()
Cure for AIDS ()
Acute HIV syndrome ()
World AIDS day ()
Western blot ()

The approval followed phase II and II trials that showed that patients who had not received previous therapy saw an 83 percent lower viral load after they took Edurant along with other antiretroviral drugs.

HIV/AIDS Risk Calculator
The HIV risk quiz helps you determine risk factors for HIV.

Side effects included depression, insomnia, headache and rash.

Source-AFP

HIV Drugs May Target Malarial Parasites in the Future
Scientists have discovered that drugs used to treat HIV may also one day become lifesaving drugs targeted at parasitic diseases such as leishmaniasis and malaria.